Genetic Variants and Oxidative Stress as Links Between Periodontitis and Metabolic Syndrome
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Catania, Italy
- University of Catania
-
-
-
-
-
London, United Kingdom, EN54LU
- UCL
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Caucasian ethnicity
- Age 18- 75
- Diagnosis of metabolic syndrome
- Presence of at least 12 teeth
Exclusion Criteria:
- Pregnancy
- Presence of infectious diseases such as hepatitis and HIV
- Use of non-steroidal anti-inflammatory drugs (excluding low-dose aspirin) within one month prior to the baseline visit
- Use of systemic antibiotics within three months prior to the baseline visit
- Antibiotic pre-medication required for the performance of periodontal examination
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
pulse wave velocity
Time Frame: baseline
|
baseline
|
|
oxidative stress
Time Frame: baseline
|
baseline
|
|
carotid intima-media thickness
Time Frame: baseline
|
baseline
|
|
genetic variants
Time Frame: baseline
|
baseline
|
|
left ventricular mass
Time Frame: baseline
|
baseline
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
inflammatory markers
Time Frame: baseline
|
baseline
|
|
subgingival microbes
Time Frame: baseline
|
baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 4242/01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.